Study explores milk oligosaccharides for low-birth-weight piglets
Bottom line
A study in Animals reports that supplementing neonatal suckling piglets with compound milk oligosaccharides, or CMO, improved several measures tied to gut and immune health, with particular interest in how low-birth-weight piglets responded. In the trial, 40 newborn piglets from 10 sows were split by birth weight into normal-birth-weight and low-birth-weight groups, then assigned to receive either CMO or a control treatment. The authors said CMO supported growth performance, immune function, and intestinal health during the neonatal suckling period, an especially vulnerable window for piglets with lower birth weights. More broadly, milk oligosaccharides are being studied as functional carbohydrates that can shape gut microbiota, strengthen barrier integrity, and influence immune development in pigs. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals working in swine health and production medicine, the study adds to a growing body of evidence that early-life nutritional interventions may help narrow the performance and health gap between low-birth-weight and normal-birth-weight piglets. That matters because low birth weight is common in large litters and is associated with poorer early survival, slower growth, and weaker gut resilience. Prior piglet studies with oligosaccharides have shown mixed but generally encouraging signals, including improved average daily gain, better intestinal development, and, in some cases, lower post-weaning mortality, suggesting this is a promising but still developing nutrition strategy rather than a settled standard of care. (pmc.ncbi.nlm.nih.gov)
What to watch: Watch for follow-up work that clarifies which oligosaccharide blends, doses, and delivery windows produce meaningful benefits in commercial herds, especially for low-birth-weight piglets through weaning. (pmc.ncbi.nlm.nih.gov)
A new paper in Animals examines whether compound milk oligosaccharides can improve growth performance, immune function, and intestinal health in neonatal suckling piglets, with a specific focus on differences between normal-birth-weight and low-birth-weight animals. That focus is important because low-birth-weight piglets remain one of the most difficult management and health challenges in modern swine production, where larger litters can increase variation in neonatal viability and gut maturity. (mdpi.com)
The study design, as described in the paper abstract, included 40 neonatal piglets from 10 lactating sows of the same parity and litter size. Each sow contributed both normal-birth-weight and low-birth-weight piglets, allowing the researchers to compare responses by birth-weight class while testing whether CMO supplementation changed outcomes tied to growth, immunity, and intestinal status. While the abstract provided in the source summary does not include every endpoint result, the framing is consistent with a broader research push to use bioactive milk carbohydrates as early-life nutritional tools rather than relying only on later post-weaning interventions. (mdpi.com)
That broader context matters. Reviews of the literature describe milk oligosaccharides as bioactive components that can support beneficial gut microbes, reduce pathogen binding, and influence mucosal immunity and barrier function in pigs. Porcine milk naturally contains a diverse set of oligosaccharides, and researchers have been exploring whether supplemental forms, including galacto-oligosaccharides, short-chain fructo-oligosaccharides, and porcine or bovine milk oligosaccharide preparations, can reproduce some of those biological effects in commercial settings. (pubmed.ncbi.nlm.nih.gov)
The evidence so far is encouraging, but not uniform. In one neonatal suckling piglet study, early galacto-oligosaccharide supplementation increased average daily gain in the third week and improved jejunal development markers. In another field trial, short-chain fructo-oligosaccharide supplementation during suckling improved body weight and was associated with reduced post-weaning mortality. But not every trial has found clear benefits: a study focused on low-birth-weight piglets reported that drenching bovine colostrum, quercetin, or fructo-oligosaccharides did not improve health or survival, underscoring how response may depend on dose, compound type, timing, and the baseline condition of the piglets. (pmc.ncbi.nlm.nih.gov)
Recent work also suggests the biology may be structure-dependent. A 2025 study in weaned pigs found that different milk oligosaccharides did not perform equally: 2'-fucosyllactose and 3'-sialyllactose showed stronger effects than galacto-oligosaccharides on nutrient absorption, barrier integrity, and immune-related measures. That doesn't directly answer what happens in newborn suckling piglets, but it does support the idea that “CMO” is not just a generic prebiotic label. The composition of the blend likely matters, especially if the goal is to support vulnerable low-birth-weight animals during the first days of life. (pubmed.ncbi.nlm.nih.gov)
Expert commentary directly tied to this specific paper was limited in publicly indexed sources, but the industry and academic discussion around piglet oligosaccharides has been fairly consistent: these compounds are promising because they target gut development at a time when piglets are immunologically immature and highly dependent on intestinal function for survival and growth. Reviews also note that practical adoption depends on more than biological plausibility. Producers and veterinarians need evidence on labor demands, delivery method, cost, consistency under commercial conditions, and whether early benefits carry through weaning and beyond. (mdpi.com)
Why it matters: For veterinary professionals, this study is most useful as another signal that precision neonatal nutrition may become a more important part of herd health strategy, especially for low-birth-weight piglets. If compound milk oligosaccharides can reliably improve gut integrity and immune readiness early in life, they could complement existing approaches aimed at reducing pre-weaning losses, supporting more uniform litters, and improving post-weaning resilience. But the field is still in the evidence-building stage. Results across oligosaccharide classes are mixed, and the practical veterinary question is no longer whether these molecules are biologically interesting, but which formulations work, in which piglets, and with what measurable return in commercial systems. (pmc.ncbi.nlm.nih.gov)
What to watch: The next step is likely more targeted work on formulation and use-case, including whether specific oligosaccharide combinations benefit low-birth-weight piglets more than normal-birth-weight littermates, and whether those gains persist through weaning, disease challenge, and overall production performance. Recent studies on porcine milk oligosaccharides in nursery pigs and systematic reviews of suckling-piglet interventions suggest that the field is moving toward more precise, mechanism-based applications rather than one-size-fits-all supplementation. (pubmed.ncbi.nlm.nih.gov)
Common questions
What did the study test in neonatal piglets?
It tested whether compound milk oligosaccharides, or CMO, affected growth performance, immune function, and intestinal health in neonatal suckling piglets.Did the study look at low-birth-weight piglets?
Yes. The trial split 40 newborn piglets from 10 sows into normal-birth-weight and low-birth-weight groups, then assigned them to CMO or a control treatment.What benefits did the authors report for CMO?
The authors said CMO supported growth performance, immune function, and intestinal health during the neonatal suckling period.Why is this research important for piglets with low birth weight?
Low-birth-weight piglets are described as especially vulnerable, and the study adds to evidence that early-life nutrition may help narrow the health and performance gap between low-birth-weight and normal-birth-weight piglets.